From: Clinical features of hepatocellular carcinoma with hepatitis B virus among patients on Nucleos(t) ide analog therapy
Anti-viral group
n = 33(%)
Non anti-viral group
n = 43(%)
P value
Prognosis
Survival
30(90.91%)
14(32.54%)
< 0.05
Death
3(9.09%)
29(67.46%)